HOG
39
5
JWN
67
2
KIM
73
4
RSG
70
2
GLW
55
2
AIZ
64
7
PCG
85
2
QRVO
43
3
CA
14
10
ECL
72
2
URBN
50
2
MAC
74
3
CSCO
67
4
XRAY
28
5
EMN
56
-4
DFS
73
2
AAPL
46
-2
PX
63
3
UNM
74
2
UPS
48
5
HOG
39
5
JWN
67
2
KIM
73
4
RSG
70
2
GLW
55
2
AIZ
64
7
PCG
85
2
QRVO
43
3
CA
14
10
ECL
72
2
URBN
50
2
MAC
74
3
CSCO
67
4
XRAY
28
5
EMN
56
-4
DFS
73
2
AAPL
46
-2
PX
63
3
UNM
74
2
UPS
48
5
Financhill
Back

Praxis Precision Medicines Vs. Kymera Therapeutics Industry Stock Comparison

Sell
47

PRAX
Praxis Precision Medicines

Last Price:
74.93
Seasonality Move:
71.13%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
47
Praxis Precision Medicines (PRAX) is a Sell

Is Praxis Precision Medicines a Buy, Sell or Hold?

  • The current Praxis Precision Medicines [PRAX] share price is $74.06. The Score for PRAX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PRAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PRAX Stock Price Chart

What is Praxis Precision Medicines's stock price today?

  • The Praxis Precision Medicines share price today is $74.06
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.51 Buy
Relative Strength Index (14 RSI): 70.47 Buy
Chaikin Money Flow: 262316 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.32 - 66.6) Buy
Bollinger Bands (100): (44.11 - 60.83) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

PRAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.69 Buy
20-day SMA: 62.75 Buy
50-day SMA: 57.86 Buy
200-day SMA: 49.77 Buy
8-day EMA: 67.94 Buy
20-day EMA: 63.91 Buy
50-day EMA: 59.26 Buy
200-day EMA: 49.06 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Praxis Precision Medicines Earnings Growth & PRAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.92 per share, and a decrease next year of $0.31 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Praxis Precision Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):